Fatigue in Rheumatologic Diseases

Physical Medicine and Rehabilitation Clinics of North America

Volumn 20, Issue 2, 2009, Pages 373-387

  Pan, John C ^a   Bressler, David N ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Elmhurst Hospital   (United States)

Author keywords

Chronic fatigue syndrome; Cognitive behavioral therapy; Exercise; Fatigability; Fatigue; Fibromyalgia; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; AMITRIPTYLINE; CYCLOBENZAPRINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DULOXETINE; METHOTREXATE; MODAFINIL; PLACEBO; PREGABALIN; PSYCHOSTIMULANT AGENT; RITUXIMAB; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TUMOR NECROSIS FACTOR INHIBITOR;

CHRONIC FATIGUE SYNDROME; CLINICAL ASSESSMENT; CLINICAL TRIAL; COGNITIVE THERAPY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSTHYMIA; ENERGY CONSERVATION; FATIGUE; FIBROMYALGIA; FOOD AND DRUG ADMINISTRATION; HUMAN; KINESIOTHERAPY; LIFESTYLE MODIFICATION; OSTEOARTHRITIS; PAIN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; RANGE OF MOTION; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SLEEP DISORDER; SOMNOLENCE; VISUAL ANALOG SCALE;

DISABILITY EVALUATION; FATIGUE; HUMANS; INCIDENCE; RHEUMATIC DISEASES; UNITED STATES;

EID: 64849104951     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmr.2008.12.008     Document Type: Review

References (66)

1. In: Gonzalez E.G., Myers S.J., Edelstein J.E., et al. (Eds). Physiologic basis of rehabilitation medicine. 3rd edition vol. 16 (2004), Butterworth Heinemann, Massachusetts 392
2. Unexplained Fatigue in the Elderly-June 25-26, 2007 Workshop Summary. National Institute on Aging Website. Available at:. http://www.nia.nih.gov/ResearchInformation/ConferencesAndMeetings/Unexpl ainedFatigue.htm Updated April 17, 2008. Accessed August 21, 2008
3. Wolfe F., and Pincus T. Listening to the patient: a practical guide to self-report questionnaires in clinical care. Arthritis Rheum 42 9 (1999) 1797-1808
4. Wolfe F., and Michaud K. Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy. J Rheumatol 34 8 (2007) 1674-1683
5. Wolfe F. Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. J Rheumatol 31 10 (2004) 1896-1902
6. Hjollund N.H., Andersen J.H., and Bech P. Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales. Health Qual Life Outcomes 5 (2007) 12 Epub February 27, 2007
7. FACIT- Fatigue Scale. Functional assessment of chronic illness therapy website. Available at:. http://www.facit.org/qview/qlist.aspx Accessed October 7, 2008
8. Cella D., Yount S., Sorensen M., et al. Validation of the functional assessment of chronic illness therapy fatigue scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32 5 (2005) 811-819
9. Dobkin B.H. Fatigue versus activity-dependent fatigability in patients with central or peripheral motor impairments. Neurorehabil Neural Repair 22 2 (2008) 105-110
10. Pollard L.C., Choy E.H., Gonzalez J., et al. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology 45 (2006) 885-889
11. Guymer E.K., and Clauw D.J. Treatment of fatigue in fibromyalgia. Rheum Dis Clin North Am 28 2 (2002) 367-378
12. Abeles A.M., Pillinger M.H., Solitar B.M., et al. Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med 146 10 (2007) 726-734
13. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 75 (2005) 6-21
14. Geenen R., and Jacobs J.W. Fibromyalgia: diagnosis, pathogenesis, and treatment. Curr Opin Anaesthesiol 14 5 (2001) 533-539
15. El Maghraoui A., Tellal S., Achemlal L., et al. Bone turnover and hormonal perturbations in patients with fibromyalgia. Clin Exp Rheumatol 24 4 (2006) 428-431
16. Buskila D., and Press J. Neuroendocrine mechanisms in fibromyalgia-chronic fatigue. Best Pract Res Clin Rheumatol 15 5 (2001) 747-758
17. Ozgocmen S., Ozyurt H., Sogut S., et al. Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide. Rheumatol Int 26 7 (2006) 585-597
18. Zautra A.J., Fasman R., Parish B.P., et al. Daily fatigue in women with osteoarthritis, rheumatoid arthritis,and fibromyalgia. Pain 128 (2007) 128-135
19. Hamilton N.A., Affleck G., Tennen H., et al. Fibromyalgia: the role of sleep in affect and in negative event reactivity and recovery. Health Psychol 27 4 (2008) 490-497
20. Klippel J.H., Weyand C.M., and Wortmann R.L. Primer on the rheumatic diseases. 11th edition (1997), Arthritis Foundation, Atlanta (GA) p. 191
21. Moldofsky H. The significance, assessment, and management of nonrestorative sleep in fibromyalgia syndrome. CNS Spectr 13 3 Suppl 5 (2008) 22-26
22. Moldofsky H. The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes. Joint Bone Spine 75 4 (2008) 397-402
23. Katz R.S., Heard A.R., Mills M., et al. The prevalence and clinical impact of reported cognitive difficulties (Fibrofog) in patients with rheumatic disease with and without fibromyalgia. J Clin Rheumatol 10 2 (2004) 53-58
24. Leavitt F., Katz R.S., Mills M., et al. Cognitive and dissociative manifestations in fibromyalgia. J Clin Rheumatol 8 2 (2002) 77-84
25. Glass J.M. Fibromyalgia and cognition. J Clin Psychiatry 69 Suppl 2 (2008) 20-24
26. Nishishinya B., Urrútia G., Walitt B., et al. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology (Oxford) 47 12 (2008) 1741-1746
27. Tofferi J.K., Jackson J.L., and O'Malley P.G. Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis. Arthritis Rheum 51 1 (2004) 9-13
28. Arnold L.M., Russell I.J., Diri E.W., et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 9 9 (2008) 792-805
29. Mease P.J., Russell I.J., Arnold L.M., et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 35 3 (2008) 502-514
30. Russell I.J., Mease P.J., Smith T.R., et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 136 3 (2008) 432-444
31. Ottonello M. Cognitive-behavioral interventions in rheumatic diseases. G Ital Med Lav Ergon 29 1 Suppl A (2007) A19-A23
32. García J., Simón M.A., Durán M., et al. Differential efficacy of a cognitive-behavioral intervention versus pharmacological treatment in the management of fibromyalgic syndrome. Psychol Health Med 11 4 (2006) 498-506
33. Starlanyl D., and Copeland M.E. Fibromyalgia & chronic myofascial pain: a survival manual. 2nd edition (2001), New Harbinger Publications, Oakland (CA) p. 119-27
34. Lowry T.J., and Pakenham K.I. Health-related quality of life in chronic fatigue syndrome: predictors of physical functioning and psychological distress. Psychol Health Med 13 2 (2008) 222-238
35. Gur A., and Oktayoglu P. Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: new concepts in treatment. Curr Pharm Des 14 13 (2008) 1274-1294
36. Fukuda. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 121 (1994) 953-959
37. Double blind trial of duloxetine in chronic fatigue syndrome, 2008. Clinical Trials gov. Available at:. http://www.clinicaltrials.gov/ct2/show/NCT00375973%3Fterm%3Dduloxetine%2 C%2Bchronic%2Bfatigue%2Bsyndrome&rank%3D1 Updated September 23, 2008. Accessed September 24, 2008
38. Kumar R. Approved and investigational uses of modafinil: an evidence-based review. Drugs 68 13 (2008) 1803-1839
39. Price J.R., Mitchell E., Tidy E., et al. Cognitive behaviour therapy for chronic fatigue syndrome in adults. Cochrane Database Syst Rev 16 3 (2008) CD001027
40. Nijs J., and Thielemans A. Kinesiophobia and symptomatology in chronic fatigue syndrome: a psychometric study of two questionnaires. Psychol Psychother 81 Pt 3 (2008) 273-283
41. Huyser B.A., Parker J.C., Thoreson R., et al. Predictors of subjective fatigue among individuals with rheumatoid arthritis. Arthritis Rheum 41 12 (1998) 2230-2237
42. Wolfe F., Michaud K., and Pincus T. Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients. J Rheumatol 31 11 (2004) 2115-2120
43. Weinblatt M.E., Keystone E.C., Furst D.E., et al. Adalimumab, a fully human anti-tumor necrosis factor monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate-the ARMADA trial. Arthritis Rheum 54 9 (2006) 2793-2806
44. Cohen S.B., Emery P., Greenwald II M.W., et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Arthritis rheum 54 9 (2006) 2793-2806
45. Keystone E., Burmester G.R., Furie R., et al. Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Arthritis Rheum 59 6 (2008) 785-793
46. Mease P.J., Revicki D.A., Szechinski J., et al. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab-results of the dose-ranging assessment: international clinical evaluation of rituximab in rheumatoid arthritis (DANCER) trial. J Rheumatol 35 1 (2008) 20-30
47. Davis M.C., Zautra A.J., Younger J., et al. Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue. Brain Behav Immun 22 1 (2008) 24-32
48. Murphy S.L., Smith D.M., Clauw D.J., et al. The impact of momentary pain and fatigue on physical activity in women with osteoarthritis. Arthritis Rheum 59 6 (2008) 849-856
49. Sale J.E., Gignac M., and Hawker G. The relationship between disease symptoms, life events, coping and treatment, and depression among older adults with osteoarthritis. J Rheumatol 35 2 (2008) 335-342
50. Gignac M.A., Davis A.M., Hawker G., et al. "What do you expect? You're just getting older": a comparison of perceived osteoarthritis-related and aging-related health experiences in middle- and older-age adults. Arthritis Rheum 55 6 (2006) 905-912
51. Power J.D., Badley E.M., French M.R., et al. Fatigue in osteoarthritis: a qualitative study. BMC Musculoskelet Disord 9 (2008) 63
52. Brosseau L., Wells G.A., Tugwell P., et al. Ottawa Panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Phys Ther 88 7 (2008) 857-871
53. Brosseau L., Wells G.A., Tugwell P., et al. Ottawa Panel evidence-based clinical practice guidelines for strengthening exercises in the management of fibromyalgia: part 2. Phys Ther 88 7 (2008) 873-886
54. Valkeinen H., Alén M., Häkkinen A., et al. Effects of concurrent strength and endurance training on physical fitness and symptoms in postmenopausal women with fibromyalgia: a randomized controlled trial. Arch Phys Med Rehabil 89 9 (2008) 1660-1666
55. Ottawa Panel. Ottawa panel evidence-based clinical practice guidelines for therapeutic exercises and manual therapy in the management of osteoarthritis. Phys Ther 85 9 (2005) 907-971
56. Ottawa Panel. Ottawa Panel evidence-based clinical practice guidelines for therapeutic exercises in the management of rheumatoid arthritis in adults. Phys Ther 84 10 (2004) 934-972
57. Neuberger G.B., Aaronson L.S., Gajewski B., et al. Predictors of exercise and effects of exercise on symptoms, function, aerobic fitness, and disease outcomes of rheumatoid arthritis. Arthritis Rheum 57 6 (2007) 943-952
58. de Jong Z., Munneke M., Zwinderman A.H., et al. Long term high intensity exercise and damage of small joints in rheumatoid arthritis. Ann Rheum Dis 63 11 (2004) 1399-1405
59. van den Ende C.H., Breedveld F.C., le Cessie S., et al. Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial. Ann Rheum Dis 59 8 (2000) 615-621
60. van den Ende C.H., Hazes J.M., le Cessie S., et al. Comparison of high and low intensity training in well controlled rheumatoid arthritis. Results of a randomised clinical trial. Ann Rheum Dis 55 11 (1996) 798-805
61. Bilberg A., Ahlmén M., and Mannerkorpi K. Moderately intensive exercise in a temperate pool for patients with rheumatoid arthritis: a randomized controlled study. Rheumatology (Oxford) 44 4 (2005) 502-508
62. Pollo F.E., and Jackson R.W. Knee bracing for unicompartmental osteoarthritis. J Am Acad Orthop Surg 14 1 (2006) 5-11
63. Warden S.J., Hinman R.S., Watson Jr. M.A., et al. Patellar taping and bracing for the treatment of chronic knee pain: a systematic review and meta-analysis. Arthritis Rheum 59 1 (2008) 73-83
64. Hammond A., and Freeman K. One-year outcomes of a randomized controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis. Rheumatology (Oxford) 40 9 (2001) 1044-1051
65. Barry M.A., Purser J., Hazleman R., et al. Effect of energy conservation and joint protection education in rheumatoid arthritis. Br J Rheumatol 33 12 (1994) 1171-1174
66. Wolfe F., Smythe H.A., and Yunus M.B. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Repot of the multicenter criteria committee. Arthritis Rheum 33 (1990) 160-172